Motley Fool Money

-- Scott is joined by Motley Fool analyst Kate Lee to talk about defence and civil contractor Droneshield (ASX:DRO): What it does, what’s impressive, the risks of an investment in the company, and why she thinks it’s a Buy! See omnystudio.com/listener for privacy information.

-- Why do shares fall after a good report? -- Is Square really buying Afterpay if they're using shares? -- What's going on with Soul Patts? -- How do we research a potential investment? -- Expense or capitalise? Does it matter? -- Keep investing, or wait for the fat pitch? -- Are 8-10% market returns real? -- How do I know if I'll get a tax statement? See omnystudio.com/listener for privacy inform...

-- Fed about to move, RBA likely to follow -- Have the Millennials finally won? -- Woolies suffers a COVID hangover -- CSL on the acquisition trail… with biggest cap raising ever on the ASX -- Vulcan energy gets an apology from the short-sellers See omnystudio.com/listener for privacy information.

Scott is joined by Motley Fool analyst Chris Copley to talk about allied health aggregator Healthia (ASX:HLA): What it does, what’s impressive, the risks of an investment in the company, and why he thinks it’s a Buy! See omnystudio.com/listener for privacy information.

-- The US is beating the ASX. Should I invest there? -- How can I explain high prices to my friends? -- Why doesn't Scott own a broader ASX ETF? -- Should I sell? Double down? Buy a basket? -- Will crypto kill payments companies? -- How do I evaluate success... and then what? See omnystudio.com/listener for privacy information.

-- Rates on hold… RBA drops target language, remains patient -- A digital dollar? -- Regulating the monsters -- Afterpay might make you pay -- Don’t we need energy stocks in a portfolio? See omnystudio.com/listener for privacy information.

Scott is joined by Motley Fool analyst Benny Ou to talk about online RV and caravan marketplace Camplify (ASX:CHL): What it does, what’s impressive, the risks of an investment in the company, and why he thinks it’s a Buy! See omnystudio.com/listener for privacy information.

-- How many stocks -- and services -- is too many? -- Do we worry about "P/E compression"? -- Help. My conviction is waning! -- Why is Kogan having such a bad run? -- How do investors think about yearly performance? -- Should I see a financial adviser? See omnystudio.com/listener for privacy information.

-- Omigod, Omicron -- Maybe inflation isn't transitory? -- The best bad news in ages -- Does reputation matter? -- What's in a name? See omnystudio.com/listener for privacy information.

Unfortunately, operator error means this week's episode isn't available via podcast. Sorry Fools! See omnystudio.com/listener for privacy information.

-- A little bit of positive feedback -- Why aren't my favourite ETFs available in my Super fund? -- Why are you guys giving stuff away for free? -- Can I just buy an ETF and avoid the risk? -- How can I get a job in the investing world? -- What crypto app should I use? See omnystudio.com/listener for privacy information.

--The bond market says rates will go up 1.4% by April 2023! -- The end of the housing boom? -- $4 billion for Black Friday -- A super-investor's warning for ‘defensive’ investors See omnystudio.com/listener for privacy information.

Scott is joined by Motley Fool analyst Andrew Legget to talk about medical technology company Nanosonics (ASX:NAN): What it does, what’s impressive, the risks of an investment in the company, and why he thinks it’s a Buy! See omnystudio.com/listener for privacy information.

-- How do execs and directors avoid insider trading? -- Are insider transactions good signals? -- What's happening to PolyNovo and Volpara? -- How do you find out the fair value of a fund? -- Will Web 3.0 kill the big tech companies? -- I'm young, and own 30 companies. How do I manage from here? See omnystudio.com/listener for privacy information.

-- What? Scott bought Fortescue? -- Rates, inflation and wages. We're not in Kansas any more, Toto -- CBA's 20% growth disappoints investors -- Don't pay twice for quality -- ETFs ain't ETFs See omnystudio.com/listener for privacy information.

Scott is joined by Motley Fool Director of Research Kevin Gandiya to talk about pathology services growth story Australian Clinical Labs (ASX:ACL): What it does, what’s impressive, the risks of an investment in the company, and why he thinks it’s a Buy!   See omnystudio.com/listener for privacy information.

-- How can I find out what stocks my ETFs hold? -- Does it matter what I value a company for, if the market disagrees? -- What would we buy if the market tanked 20%? -- How should I factor currency movements into my overseas share portfolio? -- Where can I find 'short selling' stats... and should I care? -- Isn't Ram's Bitcoin thesis busted? -- What about Bitcoin's market-cap? See omnystudio.com/l...

-- Pushpay falls off a cliff... value or value trap? -- How to think about -- and value -- companies at different lifestages -- Efficiency is the enemy of long term success -- A new EV-maker... with a $140b market cap See omnystudio.com/listener for privacy information.

Scott is joined by Motley Fool analyst Andrew Legget to talk about space and defence contractor Electro Optic Systems (ASX:EOS): What it does, what’s impressive, the risks of an investment in the company, and why he thinks it’s a Buy!     See omnystudio.com/listener for privacy information.

-- You want me to pay *how much* for Australian Ethical (ASX:AEF)? -- Help me find a small cap fund to invest in -- What's Andrew's investment thesis for cryptocurrencies? See omnystudio.com/listener for privacy information.

-- The power of incentives -- The RBA kinda gives up -- What if inflation isn’t so bad? -- Iron ore keeps falling… time to buy? -- Westpac disappoints See omnystudio.com/listener for privacy information.

Scott is joined by Motley Fool analyst Ryan Newman to talk about funds management owner and administrator Pinnacle Investment Management (ASX:PNI): What it does, what’s impressive, the risks of an investment in the company, and why he thinks it’s a Buy!     See omnystudio.com/listener for privacy information.

-- Should we buy shares in Truth? -- Companies are like sharks... -- China, Taiwan and margin loans -- Should I invest in Sequioa? -- Where can I get the Vanguard index chart? -- No-one knows my best-performing investments -- I have an idea... -- What to do if my company delists?   See omnystudio.com/listener for privacy information.

-- Prices are up... rates to follow? -- Prepare for hyperinflation... or stagflation? -- The risks - and benefits - of disruption -- Tesla hits a Trillion -- Here come the Bitcoin ETFs   See omnystudio.com/listener for privacy information.

Scott is joined by Motley Fool analyst Drew Flowers to talk about insurance broker Steadfast (ASX:SDF): What it does, what’s impressive, the risks of an investment in the company, and why he thinks it’s a Buy! See omnystudio.com/listener for privacy information.